Christoph Seidel Selected Research

Christoph Seidel Research Topics

Disease

15	Neoplasms (Cancer) 12/2023 - 01/2011
14	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2024 - 01/2016
12	Renal Cell Carcinoma (Grawitz Tumor) 02/2014 - 01/2011
5	Seminoma 12/2023 - 01/2016
3	Testicular Neoplasms (Testicular Cancer) 12/2022 - 04/2016
3	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2011
2	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 07/2008
2	Carcinoma (Carcinomatosis) 02/2016 - 03/2013
1	Head and Neck Neoplasms (Head and Neck Cancer) 02/2024
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 01/2024
1	Hyperthyroidism 01/2024
1	Cicatrix (Scar) 11/2023
1	Cardiotoxicity 11/2023
1	Body Weight (Weight, Body) 01/2022
1	Lymphatic Metastasis 01/2022
1	Disease Progression 01/2022
1	Hemorrhage 09/2021
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2021
1	Venous Thromboembolism 01/2020
1	Lymphadenopathy 01/2020
1	Nonseminomatous germ cell tumor 11/2019
1	Vision Disorders (Hemeralopia) 07/2017
1	Nausea 01/2017
1	Pain (Aches) 01/2017
1	Urogenital Neoplasms 01/2017
1	Residual Neoplasm 01/2016
1	Penile Neoplasms (Penile Cancer) 12/2013
1	Urinary Bladder Neoplasms (Bladder Cancer) 12/2013
1	Liver Cirrhosis (Hepatic Cirrhosis) 05/2012
1	Liver Diseases (Liver Disease) 05/2012
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 05/2012
1	Hyperlipidemias (Hyperlipidemia) 04/2011
1	Pneumonia (Pneumonitis) 04/2011
1	Sarcoma (Soft Tissue Sarcoma) 04/2011
1	Stomatitis 04/2011
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 04/2011
1	Infections 04/2011
1	Hyperglycemia 04/2011
1	Obesity 01/2011
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 07/2008

Drug/Important Bio-Agent (IBA)

7	Cisplatin (Platino)FDA LinkGeneric 02/2022 - 01/2016
3	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 01/2024 - 01/2020
3	PlatinumIBA 11/2023 - 01/2018
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014 - 01/2011
3	C-Reactive ProteinIBA 12/2013 - 09/2012
2	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 07/2008
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2014
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2021 - 01/2020
2	Etoposide (VP 16)FDA LinkGeneric 01/2019 - 01/2016
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2019 - 01/2016
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2011 - 07/2011
2	Tyrosine Kinase InhibitorsIBA 07/2011 - 01/2011
2	Everolimus FDA Link 04/2011 - 01/2011
2	MTOR InhibitorsIBA 04/2011 - 01/2011
1	Thyrotropin Receptors (Thyrotropin Receptor)IBA 01/2024
1	RNA (Ribonucleic Acid)IBA 12/2023
1	plerixafor FDA Link 01/2022
1	CX-PlusIBA 01/2022
1	NivolumabIBA 01/2022
1	Androgen Receptors (Androgen Receptor)IBA 01/2022
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2022
1	Mediator Complex Subunit 1IBA 01/2022
1	vinyltriethoxysilane (VTES)IBA 09/2021
1	COVID-19 VaccinesIBA 01/2021
1	cabazitaxel FDA Link 02/2020
1	Tumor Biomarkers (Tumor Markers)IBA 11/2019
1	Cytostatic AgentsIBA 01/2018
1	Retinaldehyde (Retinal)IBA 07/2017
1	Analgesics (Analgesic Drugs)IBA 01/2017
1	N- succinimidyl- 5- iodo- 3- pyridinecarboxylic acidIBA 01/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 04/2016
1	Gemcitabine FDA Link 04/2016
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2016
1	vinflunineIBA 02/2016
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 02/2014
1	Imatinib Mesylate (Gleevec)FDA Link 05/2012
1	CytokinesIBA 05/2012
1	temsirolimus FDA Link 04/2011
1	Sunitinib (Sutent)FDA Link 01/2011

Therapy/Procedure

13	Therapeutics 12/2022 - 01/2011
12	Drug Therapy (Chemotherapy) 11/2023 - 12/2013
2	Radiotherapy 12/2022 - 01/2022
2	Combination Drug Therapy (Combination Chemotherapy) 01/2018 - 01/2016
1	Chemoradiotherapy 02/2024
1	Enteral Nutrition (Feeding, Tube) 02/2024
1	Combined Modality Therapy 12/2022
1	Hematopoietic Stem Cell Mobilization 01/2022
1	Prostatectomy (Retropubic Prostatectomy) 01/2022
1	Vascular Access Devices (Arterial Line) 01/2020
1	Palliative Care (Palliative Therapy) 01/2017
1	Orchiectomy (Orchidectomy) 01/2016